BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37553571)

  • 1. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
    Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
    BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
    Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
    J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study.
    Watcharatanyatip K; Chutipongtanate S; Chokchaichamnankit D; Weeraphan C; Mingkwan K; Luevisadpibul V; Newburg DS; Morrow AL; Svasti J; Srisomsap C
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
    Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
    Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
    Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
    J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
    Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
    Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.
    Aung TM; Ciin MN; Silsirivanit A; Jusakul A; Lert-Itthiporn W; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():836985. PubMed ID: 35392474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
    Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
    BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring.
    Wen N; Peng D; Xiong X; Liu G; Nie G; Wang Y; Xu J; Wang S; Yang S; Tian Y; Li B; Lu J; Cheng N
    Signal Transduct Target Ther; 2024 May; 9(1):107. PubMed ID: 38697972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinoma.
    Muraki R; Morita Y; Ida S; Kitajima R; Furuhashi S; Takeda M; Kikuchi H; Hiramatsu Y; Takanashi Y; Hamaya Y; Sugimoto K; Ito J; Kawata K; Kawasaki H; Sato T; Kahyo T; Setou M; Takeuchi H
    Cancer Med; 2023 Jun; 12(12):13007-13018. PubMed ID: 37096775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDLM: Ensemble Deep Learning Model to Detect Mutation for the Early Detection of Cholangiocarcinoma.
    Shah AA; Alturise F; Alkhalifah T; Faisal A; Khan YD
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
    Duangkumpha K; Stoll T; Phetcharaburanin J; Yongvanit P; Thanan R; Techasen A; Namwat N; Khuntikeo N; Chamadol N; Roytrakul S; Mulvenna J; Mohamed A; Shah AK; Hill MM; Loilome W
    PLoS One; 2019; 14(8):e0221024. PubMed ID: 31425520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated microfluidic system for automatic detection of cholangiocarcinoma cells from bile.
    Chang JL; Huang CJ; Tsai YC; Chiang NJ; Huang YS; Hung SC; Shan YS; Lee GB
    Lab Chip; 2024 Jan; 24(2):375-382. PubMed ID: 38126571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.